Literature DB >> 2062837

Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms.

A R Karlström1, R L Levine.   

Abstract

The protease of the human immunodeficiency virus is essential for replication of the virus, and the enzyme is therefore an attractive target for antiviral action. We have found that the viral protease is inhibited by approximately stoichiometric concentrations of copper or mercury ions. Inactivation by Cu2+ was rapid and not reversed by subsequent exposure to EDTA or dithiothreitol. Direct inhibition by Cu2+ required the presence of cysteine residue(s) in the protease. Thus, a synthetic protease lacking cysteine residues was not inhibited by exposure to copper. However, addition of dithiothreitol as an exogenous thiol rendered even the synthetic protease susceptible to inactivation by copper. Oxygen was not required for inactivation of either the wild-type or the synthetic protease. These results provide the basis for the design of novel types of protease inhibitors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062837      PMCID: PMC51915          DOI: 10.1073/pnas.88.13.5552

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Complete mutagenesis of the HIV-1 protease.

Authors:  D D Loeb; R Swanstrom; L Everitt; M Manchester; S E Stamper; C A Hutchison
Journal:  Nature       Date:  1989-08-03       Impact factor: 49.962

2.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1.

Authors:  M A Navia; P M Fitzgerald; B M McKeever; C T Leu; J C Heimbach; W K Herber; I S Sigal; P L Darke; J P Springer
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

Review 3.  Viral proteinases.

Authors:  H G Kräusslich; E Wimmer
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 4.  A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals.

Authors:  M Chevion
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

5.  Structure and refinement at 1.8 A resolution of the aspartic proteinase from Rhizopus chinensis.

Authors:  K Suguna; R R Bott; E A Padlan; E Subramanian; S Sheriff; G H Cohen; D R Davies
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

6.  Crystal structure of a retroviral protease proves relationship to aspartic protease family.

Authors:  M Miller; M Jaskólski; J K Rao; J Leis; A Wlodawer
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

7.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

8.  Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.

Authors:  T D Meek; B D Dayton; B W Metcalf; G B Dreyer; J E Strickler; J G Gorniak; M Rosenberg; M L Moore; V W Magaard; C Debouck
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease.

Authors:  P L Darke; C T Leu; L J Davis; J C Heimbach; R E Diehl; W S Hill; R A Dixon; I S Sigal
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

10.  Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation.

Authors:  S F Le Grice; J Mills; J Mous
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

View more
  22 in total

1.  Neutralizing viruses in suspensions by copper oxide-based filters.

Authors:  Gadi Borkow; Robert W Sidwell; Donald F Smee; Dale L Barnard; John D Morrey; Humberto H Lara-Villegas; Yonat Shemer-Avni; Jeffrey Gabbay
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

Review 2.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

3.  Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs.

Authors:  U Nillroth; L Vrang; P O Markgren; J Hultén; A Hallberg; U H Danielson
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

4.  The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active.

Authors:  Huogen Xiao; Brian C Bryksa; Prasenjit Bhaumik; Alla Gustchina; Yoshiaki Kiso; Shao Q Yao; Alexander Wlodawer; Rickey Y Yada
Journal:  Mol Biochem Parasitol       Date:  2014-10-25       Impact factor: 1.759

5.  Identification of a functional homolog of the yeast copper homeostasis gene ATX1 from Arabidopsis.

Authors:  E Himelblau; H Mira; S J Lin; V C Culotta; L Peñarrubia; R M Amasino
Journal:  Plant Physiol       Date:  1998-08       Impact factor: 8.340

6.  Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  A novel anti-influenza copper oxide containing respiratory face mask.

Authors:  Gadi Borkow; Steve S Zhou; Tom Page; Jeffrey Gabbay
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

8.  Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions.

Authors:  D A Davis; K Yusa; L A Gillim; F M Newcomb; H Mitsuya; R Yarchoan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 9.  Transcription factor IIIA (TFIIIA): an update.

Authors:  B S Shastry
Journal:  Experientia       Date:  1993-10-15

10.  Deactivation of human immunodeficiency virus type 1 in medium by copper oxide-containing filters.

Authors:  Gadi Borkow; Humberto H Lara; Chandice Y Covington; Adeline Nyamathi; Jeffrey Gabbay
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.